Skip to main content

and
  1. Article

    Open Access

    Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

    Despite the improvements in clinical outcomes for DLBCL, a significant proportion of patients still face challenges with refractory/relapsed (R/R) disease after receiving first-line R-CHOP treatment. To furthe...

    Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, **anhuo Wang in Leukemia (2024)

  2. Article

    Open Access

    Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+ Expression in Tumor

    Mesothelin (MSLN) is overexpressed in several tumors including ovarian cancer and is the target of current trials. There is limited and conflicting data on MSLN prognostic impact in ovarian cancer.

    Isabelle Magalhaes, Josefin Fernebro, Sulaf Abd Own, Daria Glaessgen in Advances in Therapy (2020)